Mid-Atlantic Lays Claim to Majority of Pharma-Biotech's $3.5 Billion Investment in Construction Starts in First-Quarter 2014

SUGAR LAND--February 11, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Virtually every region of North America is home to some form of construction activity sourced out of the Pharmaceutical-Biotech Industry, with plans to kick off $3.5 billion in the form of 165 projects in the first three months of the year. Laying claim to the biggest slice of that lucrative pie is the Mid-Atlantic region, with $783 million divided among 19 projects on the books for a first-quarter 2014 kickoff. Other companies featured: Colgate-Palmolive (NYSE:CL), AstraZeneca (NYSE:AZN), Bristol-Myers Squibb (NYSE:BMY)